Menu
Text Down Text Up
Social Social
Call us now on 1300 466 324
Title

Pharmaceutical Companies

Celgene

Azacitidine (Vidaza®) Injection Program (CLOSED 31st August 2017)

This program is funded by Celgene and is to help patients with myelodysplastic syndrome (MDS) and some types of leukaemia have their Azacitidine (Vidaza®) treatment at home.  Patients do not need to have private health insurance to access this program.

Janssen

Bortezomib (Velade®) Pathways Program (WA, SA)

This program is funded by Janssen and is to help patients with multiple myleoma have their Bortezomib (Velade®) treatment at home.  Patients do not need to have private health insurance to access this program.

BMS

Abatacept (Orencia®) Program (WA)

This program is funded by BMS and is to help patients with rheumatoid arthritis have their abatacept (Orencia®) treatment at home.  Patients do not need to have private health insurance to access this program.

 

Contact Form

  • This field is for validation purposes and should be left unchanged.